ARCHIVES

No Benefit For Cetuximab In Early-Stage Colon Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

Breast Cancer Task Force Hears Update on Research, Abstract Excerpter

September 19, 1980

Drug Development Gets Extra $500,000

November 18, 1977

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991